Superworth

IDEXX Laboratories price to sales ratio IDXX

Market value divided by revenue over the last twelve months, since 2011.

Today, Oct 23, 2026
9.7×
10-year median
10.3×
Against its 10-year history
39th
percentile: 0 is its lowest day, 100 its highest
10-year range
5.5× to 20.7×
Peer median
6.5×

IDEXX Laboratories' price to sales ratio is 9.7× as of Oct 23, 2026.

That is below its ten-year median of 10.3×, close to the middle of its last ten years.

Over that time it ranged from 5.5× in Nov 2016 to 20.7× in Jul 2021.

The median for 10 diagnostics and research stocks of a similar size is 6.5×.

Price to sales ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far9.7×8.7×13.7×
202513.2×8.2×14.4×
20248.8×8.8×13.2×
202312.8×9.2×13.4×
202210.1×8.2×14.9×
202117.8×15.2×20.7×
202016.5×6.5×16.5×
20199.6×7.4×10.9×
20187.4×7.3×10.5×
20177.2×6.1×8.2×
20166.1×3.9×6.2×
20154.3×3.9×5.4×
20144.8×4.1×5.0×
20134.1×3.4×4.2×
20123.9×3.6×4.5×
20113.6×3.3×4.2×

Against its peers

Companies in Medical - Diagnostics & Research nearest IDEXX Laboratories' size, closest first, today.

CompanyPrice to sales ratio
IDXXIDEXX Laboratories9.7×
WATWaters9.6×
IQVIQVIA2.7×
ILMNIllumina9.1×
AAgilent Technologies6.6×
MTDMettler-Toledo International8.1×
DGXQuest Diagnostics2.3×
LHLabcorp1.9×
MEDPMedpace6.7×
RVTYRevvity6.1×
DHRDanaher6.5×
Peer median6.5×

Where IDEXX Laboratories ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on IDEXX Laboratories

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.